Pranav Chawla

Congratulations sir for the good set of results . I just want to understand on the bilogics, you recently announced a couple of contracts can you give some color on those contracts? When will they begin to contribute and when it should begin and how large can these contracts become for us? And do you plan to add any dedicated capacity for these?

Sir, one last thing from my end. So, within the biologics, where do you stand in the value chain for a customer? Do we also do R&D, or we are primary a CMO partner? Just trying to get some color on your biologics?

And one last question , if I may be able to squeeze in . So, from what we understand a lot of domestic players are also trying to get into the CDMO piece for biologics. Obviously, our backward integration or being able to be part of the whole supply chain does help , do you see this as a material risk going forward for our biologics offering?